Form 4: Curis Inc. Executive Granted Stock Options
Statement of Changes in Beneficial Ownership
Diantha Duvall, CFO of Curis Inc., was granted 48,285 employee stock options with an exercise price of $5.29.
Summary
- Diantha Duvall, Chief Financial Officer of Curis Inc., received a grant of employee stock options.
- The grant includes 48,285 options with an exercise price of $5.29 per share.
- These options vest over time, with 25% vesting on July 7, 2027, and an additional 6.25% vesting each quarter thereafter until July 7, 2030.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard executive compensation event (stock option grant) rather than a significant operational or financial development.
Positives
- Grant of stock options to a key executive (CFO) can align management's interests with shareholders.
- The option grant provides potential future equity value for the executive, incentivizing performance.
Risks
- The value of the stock options is contingent on the future performance of Curis Inc.'s stock price.
- If the stock price does not exceed the exercise price of $5.29, the options may not be exercised profitably.
Future Outlook
The filing itself does not contain forward-looking statements or guidance. The future outlook for the stock options is dependent on the company's stock performance.
Industry Context
StockSavvy.ai notes that the granting of stock options to executives is a common practice in the biotechnology and pharmaceutical sectors, like Curis Inc., to attract and retain talent and align executive incentives with long-term shareholder value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Diantha Duvall has appointed attorneys-in-fact to execute Section 16 reporting forms (Forms 3, 4, and 5) on her behalf. | 04/24/2026 | Facilitates timely and accurate regulatory filings for beneficial ownership changes. |
Stakeholder Impact
- Shareholders: The stock option grant aligns executive incentives with potential future stock price appreciation.
- Employees: May indicate a stable compensation structure for key executives.
- Management: Provides potential for increased personal wealth tied to company performance.
Next Steps
- Vesting of stock options according to the specified schedule.
- Potential exercise of vested stock options by Diantha Duvall.
Key Dates
| Date | Description |
|---|---|
| 07/07/2026 | Earliest transaction date and grant date of employee stock options. |
| 07/06/2036 | Expiration date of the employee stock options. |
| 07/07/2027 | First vesting date for 25% of the granted stock options. |
| 07/07/2030 | Final vesting date for all granted stock options. |
| 04/24/2026 | Date of the Power of Attorney document. |
| 07/09/2026 | Date of signature for the Form 4 filing. |
Keywords
Curis Inc., CRIS, Form 4, Stock Options, Executive Compensation, CFO, Diantha Duvall, SEC Filing, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.